May 6th 2024
Dr Goy discusses the impact of CAR T-cell therapy on the lymphoma and multiple myeloma treatment paradigms and his anticipations for the future of hematologic oncology.
February 13th 2023
Andre H. Goy, MD, discusses key findings from an assessment of durable responses in the phase 2 ZUMA-2 trial in relapsed/refractory mantle cell lymphoma.
November 15th 2022
Andre H. Goy, MD, discusses the clinical implications of treating indolent mantle cell lymphoma.
October 17th 2022
Andre H. Goy, MD, discusses clinical trial vs real-world treatments in patients with mantle cell lymphoma.
May 16th 2022
Maher Albitar, MD, and Andre H. Goy, MD, discuss case studies in diffuse large B-cell lymphoma.
May 13th 2022
Maher Albitar, MD, and Andre H. Goy, MD, discuss the importance of testing for molecular abnormalities in acute myeloid leukemia.
Maher Albitar, MD, and Andre H. Goy, MD, share insights regarding molecular complexities in mantle cell lymphoma.
May 12th 2022
Maher Albitar, MD, and Andre H. Goy, MD, discuss practical aspects of next-generation sequencing.
March 15th 2022
Lori A. Leslie, MD, and Andre H. Goy, MD, share strategies for when CAR T-cell therapy is not an option.
Lori A. Leslie, MD, and Andre H. Goy, MD, discuss approaches to CAR T-cell therapy.
March 10th 2022
Lori A. Leslie, MD, and Andre H. Goy, MD, discuss optimal strategies for CAR T-cell–related adverse effects.
Lori A. Leslie, MD, and Andre H. Goy, MD, discuss retreatment with CAR T-cell therapy.
March 9th 2022
Lori A. Leslie, MD, and Andre H. Goy, MD, discuss next steps with CAR T-cell therapy.
January 10th 2022
Andre H. Goy, MD, discusses the clinical data reported with axicabtagene ciloleucel in patients with relapsed or refractory indolent non-Hodgkin lymphoma and real-world findings with brexucabtagene autoleucel in mantle cell lymphoma.
April 8th 2021
Andre Goy, MD, discusses the clinical implications of CAR T-cell therapy in mantle cell lymphoma.
May 10th 2020
Andre H. Goy, MD, discusses the potential utility of BTK inhibitors as maintenance therapy in mantle cell lymphoma.